Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers

OBJECTIVE: To investigate the impact of mammalian target of rapamycin (mTOR) inhibitor conversion together with minimization of calcineurin inhibitor on allograft outcome and patient survival in kidney transplant recipients with post-transplant cancers. METHODS: A retrospective study of all kidney t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Chi Yuen, Ma, Maggie Kam Man, Chak, Wai Leung, Chau, Ka Foon, Tang, Sydney Chi Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546523/
https://www.ncbi.nlm.nih.gov/pubmed/28160552
http://dx.doi.org/10.18632/oncotarget.14908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546523/
https://www.ncbi.nlm.nih.gov/pubmed/28160552
http://dx.doi.org/10.18632/oncotarget.14908

Ejemplares similares